Tag Archives: AstraZeneca pauses coronavirus vaccine trial after unexplained illness in participant

LONDON: AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares on Wednesday as the move was seen as dimming prospects for an early rollout. On Tuesday, AstraZeneca said it voluntarily paused trials, including late-stage ones, to allow an independent committee to review safety data, and it was …

Read More »